Re:A Government Guide to Keeping Insulin Unaffordable
by tptacek on Monday July 08, 2019 @11:44AM
(#20383687)
I think his point is that evergreening isn't a feature of the patent system; there's no mechanism to extend a patent, and "extension" patents of minor modifications don't extend the legal monopoly on a drug, but rather function as a marketing mechanism that preys on the industry's willingness to prescribe whatever the newest iteration of a drug is, regardless of evidence.
[ Parent
| on HN ]
There are no comments on this comment yet.